# CNS Pharmaceuticals, Inc.: Form DEF 14A, filed Oct 28, 2024

- Company: [CNS Pharmaceuticals, Inc.](/companies/cnsp.md) (CIK 1729427)
- Form: DEF 14A
- Filed: 2024-10-28
- Accepted by EDGAR: Oct 28, 2024, 20:15 ET
- Period: 2024-11-26
- Accession: 0001683168-24-007416
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1729427/000168316824007416/cns_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729427/000168316824007416/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729427/000168316824007416/cns_def14a.htm

Filed Oct 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001683168-24-007416. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.